Cytarabine IT

DRUG2 trials

Sponsors

Therapeutic Advances in Childhood Leukemia Consortium, C17 Council

Conditions

ALLAMLAcute Undifferentiated LeukemiaAtypical Teratoid Rhabdoid TumorBPDCNCNS Embryonal TumorCNS Embryonal Tumor With Rhabdoid FeaturesCNS Embryonal Tumor, Nos

Early Phase 1

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

RecruitingNCT06942039

C17 CouncilAtypical Teratoid Rhabdoid Tumor, CNS Embryonal Tumor, CNS Embryonal Tumor, Nos +11

Start: 2025-09-23End: 2032-12-31Target: 15Updated: 2026-02-27

Phase 1

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingNCT05476770

Therapeutic Advances in Childhood Leukemia ConsortiumAcute Undifferentiated Leukemia, ALL, AML +8

Start: 2022-11-11End: 2027-11-11Target: 54Updated: 2024-12-06

Related Papers

Phase I Study of Tagraxofusp with or without Chemotherapy in Pediatric Patients with Relapsed or Refractory CD123-Expressing Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Trial

Blood2022-11-153 citations